Prehabilitation of Elderly Patients With Frailty Syndrome Before Elective Surgery (PRAEP-GO)

February 12, 2024 updated by: Claudia Spies, Charite University, Berlin, Germany

Prehabilitation of Elderly Frail or Pre-frail Patients Prior to Elective Surgery - a Randomized Controlled Multicenter Study (PRAEP-Go)

The aim of the study is to evaluate the effect of a shared decision-making conference and three-week prehabilitation program on the outcome "care dependency" one year after surgery. The cost-effectiveness of the intervention will also be evaluated in this N = 1400 patient, national multicenter, assessor-blinded, randomized, pragmatic, controlled, parallel-group, clinical trial.

The objective of PRÄP-GO is to establish and employ a suitable preoperative case-care management system to improve the short and long-term outcome of elderly surgical patients with signs of a frailty syndrome, improving postoperative quality of life and reducing care dependency by a three-week individualized prehabilitation program.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

1400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Bad Oeynhausen, Germany
        • Recruiting
        • Herz- und Diabetes Zentrum
      • Berlin, Germany, 12203
        • Recruiting
        • Department of Anesthesiology and Operative Intensive Care Medicine (CBF), Charité - Universitätsmedizin Berlin
        • Principal Investigator:
          • Sascha Treskatsch, MD, Prof.
        • Contact:
      • Berlin, Germany, 13353
        • Recruiting
        • Department of Anesthesiology and Operative Intensive Care Medicine CCM/CVK, Charité - Universitätsmedizin Berlin
        • Contact:
        • Principal Investigator:
          • Claudia Spies, MD, Prof.
        • Sub-Investigator:
          • Stefan Schaller, MD, Prof.
        • Sub-Investigator:
          • Katrin Schmidt, MD
      • Berlin, Germany
        • Recruiting
        • Auguste-Viktoria-Klinikum - Vivantes - Netzwerk für Gesundheit GmbH
      • Berlin, Germany
        • Recruiting
        • Bundeswehrkrankenhaus
      • Berlin, Germany
        • Recruiting
        • CARITAS Klinik Maria Heimsuchung
      • Berlin, Germany
        • Recruiting
        • Dominikus-Krankenhaus
      • Berlin, Germany
        • Recruiting
        • Evangelisches Krankenhaus Hubertus
      • Berlin, Germany
        • Not yet recruiting
        • Humboldt-Klinikum - Vivantes - Netzwerk für Gesundheit GmbH
      • Berlin, Germany
        • Recruiting
        • Klinikum im Friedrichshain - Vivantes - Netzwerk für Gesundheit GmbH
      • Berlin, Germany
        • Withdrawn
        • Martin-Luther-Krankenhaus
      • Berlin, Germany
        • Recruiting
        • Sankt Joseph Krankenhaus
      • Berlin, Germany
        • Recruiting
        • Unfallkrankenhaus Berlin
      • Frankfurt/Oder, Germany
        • Withdrawn
        • Klinikum Frankfurt Oder GmbH
      • Greifswald, Germany
        • Recruiting
        • Universitätsmedizin Greifswald
      • Hamburg, Germany
        • Recruiting
        • Universitätsklinikum Hamburg-Eppendorf
      • Kremmen, Germany
        • Recruiting
        • Sana Kliniken Sommerfeld
      • Lübeck, Germany
        • Recruiting
        • Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Universität zu Lübeck
      • München, Germany
        • Recruiting
        • Klinikum der Universität München, LMU Campus Großhadern
      • München, Germany
        • Recruiting
        • Klinikum rechts der Isar - Technische Universität München
      • München, Germany
        • Recruiting
        • München Klinik Bogenhausen
      • Nauen, Germany, 14641
        • Recruiting
        • Havelland Kliniken GmbH - Klinik Nauen
      • Rathenow, Germany, 14712
        • Active, not recruiting
        • Havelland Kliniken-Klinik Rathenow

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Study patients:

Inclusion Criteria:

  • Age ≥ 70 years
  • Consent by Patient or Legal Representative
  • Elective surgery planned
  • Expected anesthesia duration≥ 60 min
  • Statutory health insurance
  • Frailty syndrome (≥1 positive out of 5 standardized parameters according to the Physical Frailty Phenotype according to Fried et. al.)

Exclusion Criteria:

  • Severe cardiac or pulmonary disease (NYHA IV, Gold IV)
  • Intracranial interventions
  • Moribund patients (palliative situation)
  • Not enough language skills
  • Participation in another interventional rehabilitation study or other interventional clinical trial that has not been approved by the study management committee (Exception: Participation in adjuvant intervention study)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Prehabilitation
Prefrail and frail patients receive prehabilitation (new form of care)
The participants in the intervention group take part in a shared decision-making (SDM) conference to plan the intervention. The therapeutic content of the prehabilitation is defined individually for each patient in the SDM conference. Prehabilitation will be a structured and individually tailored 3-week program.
No Intervention: Standard of Care
Prefrail and frail patients receive no prehabilitation, but receive standard of care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Degree of care dependency
Time Frame: Up to one year
Assessment results in a degree of care dependency from personal help according to the German dependency assessment (= "Neues Begutachtungs-Assessment" (NBA)) (Wingenfeld et al., 2008). The results of the assessments ranges between 0 and 100 points, which are transformed into a 0-5 ordinal scale. Higher points in the assessments indicate higher demand of care dependency. Accordingly, higher numbers on the ordinal scale indicate a higher level of care dependency as defined in the German statutory care insurance program.
Up to one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neurocognitive Disorder (NCD)
Time Frame: Up to one year
New diagnosis of mild/major Neurocognitive Disorder at 3 and 12 months. The diagnosis is made based on DSM-V criteria including a multi-component cognitive test battery comparing with baseline testing and comparison to a non-surgical observational control group.
Up to one year
Suspected Neurocognitive disorder by MiniCog
Time Frame: Up to one year
Dementia is suspected by limited MiniCog-test result. The MiniCog consists of two items, the word recall test and the clock-drawing test. Performance in these test is rated on a scale ranging from 0 - 5, with <3 points indicating a suspicion of dementia.
Up to one year
Suspected Dementia by MOCA
Time Frame: Up to one year
Dementia is suspected by a Montreal Cognitive Assessment (MOCA) according to normative age-adjusted values. The MOCA consists of 13 items which are rated on a scale between 0 and 30 points.
Up to one year
Suspected postoperative neurocognitive disorder (POCD)
Time Frame: Up to one year
The non-computerized neuropsychological Trail Making Test are used as indicator screening test for relevant cognitive change after surgery. An increase of >55 seconds in TMT-B test performance at three and/or 12 months after surgery compared to baseline is set as cut off.
Up to one year
Frailty
Time Frame: Up to one year
Frailty is operationalized using modified Fried frailty criteria. Frailty scores from 0 to 5 (i.e., 1 point for each component; 0 = best to 5 = worst) represent robust (0), pre-frail (1-2), and frail (3-5) health status.
Up to one year
Polypharmacy
Time Frame: Up to one year
Measured by number of drug agents
Up to one year
Alcohol Use
Time Frame: Up to one year
Measured by number of drug agents
Up to one year
Tobacco Use
Time Frame: Up to one year
Measured by Fagerstrom (Fagerstrom & Schneider, 1989)
Up to one year
Intraoperative Neuromonitoring
Time Frame: During surgery
Monitoring of electroencephalography during surgery
During surgery
Result of surgery
Time Frame: Up to one year
Incidence of complications (intra- and post-operative)
Up to one year
Autonomy Preference
Time Frame: At the beginning of the observation
Extent of patients' autonomy preference concerning medical decisions; Autonomy-Preference-Index, modified German version (API-Dm). The scale consists of a 11-item questionnaire with 4 questions on preferred autonomy in health-related decisions and 7 items on information preference. The total results of the API and both subscales are transformed into a 0 - 100 scale with higher values indicating higher levels on autonomy and information preference, respectively.
At the beginning of the observation
Extent of involvement in shared decision-making process
Time Frame: At the beginning of the observation
Extent of patients, relatives and health professionals' involvement in shared decision-making process; 9-Item Shared Decision Making Questionnaire (SDM-Q-9/SDM-Q-Doc)
At the beginning of the observation
Arm circumference
Time Frame: Up to one year
Arm circumference is measured in a standardized position and documented in centimeter.
Up to one year
Calf circumference
Time Frame: Up to one year
Calf circumference is measured in a standardized position and documented in centimeter.
Up to one year
Sarcopenia
Time Frame: Up to one year
Sarcopenia is evaluated as a composite measure by three criteria that are assessed: 1) low muscle strength (hand grip strength), 2) low muscle quantity (calf circumference) and 3) low physical performance (gait speed).
Up to one year
Independence of Functional Status
Time Frame: Up to one year
Assessment of the patient's independence in mobilization, i.e. mobilization in daily living without personnel or device support.
Up to one year
Functional endurance
Time Frame: Up to one year
Functional endurance is measured using the 2-Minute-Step-Test (2-MST). The patient steps in place, raising each leg to a marker. The markers height is derived from biometrical measures of the patient. The assessor counts each step of the right leg in which the knee of the patient passes the marker. Higher counts of steps indicates better functional endurance.
Up to one year
Function of the respiratory system
Time Frame: Up to one year
The function of the respiratory system is assessed by expiratory peak flow measurement as surrogate parameter.
Up to one year
Depression
Time Frame: Up to one year
Depression is measured by frequency of depressive symptoms; Patient Health Questionnaire-8 (PHQ-8)]
Up to one year
Anxiety
Time Frame: Up to one year
Anxiety is measured frequency of anxiety symptoms; Generalized Anxiety Disorder Scale-7 (GAD-7)
Up to one year
Frequency of depressive and anxiety symptoms
Time Frame: Up to one year
Frequency of depressive and anxiety symptoms; Patient Health Questionnaire-4 (PHQ-4)]
Up to one year
Health related quality of life
Time Frame: Up to one year
Health related quality of life is measured with EQ-5D-5L questionnaire.
Up to one year
Patient-reported Functioning and Disability (WHO Disability Assessment) Schedule)
Time Frame: Up to one year
Patient-reported functioning and disability is measured by patient self report of functioning and disability due to health conditions; WHO Disability Assessment Schedule (WHODAS 2.0, 12-item version)
Up to one year
Proxy-reported Functioning and Disability (WHO Disability Assessment) Schedule)
Time Frame: Up to one year
Proxy-reported Functioning and Disability is measured by Proxy-rated functioning and disability due to health conditions; WHO Disability Assessment Schedule (WHODAS 2.0, 12-item Version)
Up to one year
Falls
Time Frame: Up to one year
Incidence of falls
Up to one year
Fear of Falling
Time Frame: Up to one year
Activities-Specific Balance Confidence (ABC)-6-Scale. The scale consists of 6 questions who are rated on a 0-100 NRS-scale. The total result of the ABC-6-scale comprises of the average of all 6 items.
Up to one year
Social situation measurement 1
Time Frame: Up to one year
The social situation 1 of the patient is measured by a Questionnaire for Social Situation (SOS, Subscales 1 and 2).
Up to one year
Social situation measurement 2
Time Frame: Up to one year
The social situation 2 of the patient is measured by BSSS, 8-items
Up to one year
Pain: Numeric rating scale
Time Frame: Up to one year
Pain is measured with a pain score Numeric rating scale (0-10), a higher score indicates more pain.
Up to one year
Satisfaction with the prehabilitation and overall process: ZUF-8
Time Frame: Up to one year
The satisfaction of the patient is measured with the questionnaire on patient satisfaction (ZUF-8). The ZUF-8 is a questionnaire on patient satisfaction after treatment. It consists of 8 questions which results in a score between 0 and 24 points, with higher values.indicating higher levels of satisfaction.
Up to one year
Loneliness
Time Frame: Up to one year
Frequency of sensations of loneliness; 3-item UCLA Loneliness Scale
Up to one year
Survival
Time Frame: Up to one year
Data from patient records and residents' registration
Up to one year
Nutritional Status
Time Frame: Up to one year
Changes of nutritional status after elective surgery.
Up to one year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of stay Intensive Care Unit
Time Frame: Participants are followed up for the duration of rehabilitation, an expected average of 1 day]
Intensive care unit length of stay describes every day spent in an ICU bed.
Participants are followed up for the duration of rehabilitation, an expected average of 1 day]
Admission Intensive Care Unit (ICU) Admission rate on Intensive Care Unit (ICU)
Time Frame: Participants are followed up for the duration of rehabilitation, an expected average of 1 day]
Admission rate (planned / unplanned) on ICU
Participants are followed up for the duration of rehabilitation, an expected average of 1 day]
Duration of hospital stay
Time Frame: Participants are followed up for the duration of rehabilitation, an expected average of 7 days]
Time in hospital
Participants are followed up for the duration of rehabilitation, an expected average of 7 days]
Adverse Discharge Disposition
Time Frame: Participants are followed up after hospital discharge for 1 day
Adverse discharge disposition other than to home and planned rehabilitation facility.
Participants are followed up after hospital discharge for 1 day
Necessity for follow-up treatment and rehabilitation
Time Frame: Up to one year
Assessment if a follow-up treatment or rehabilitation is necessary after the hospital stay.
Up to one year
Count of new discharge diagnoses
Time Frame: Participants are followed up for the duration of rehabilitation, an expected average of 7 days]
New medical diagnoses at hospital discharge compared to baseline are assessed.
Participants are followed up for the duration of rehabilitation, an expected average of 7 days]
Count of new discharge medication
Time Frame: Participants are followed up for the duration of rehabilitation, an expected average of 7 days]
New medication at hospital discharge compared to baseline is assessed.
Participants are followed up for the duration of rehabilitation, an expected average of 7 days]
Duration of rehabilitation
Time Frame: Participants are followed up for the duration of rehabilitation, an expected average of 25 days]
Patient record data, discharge letter
Participants are followed up for the duration of rehabilitation, an expected average of 25 days]
Health economic benefit
Time Frame: Up to one year
ScreeningThe health economic benefit of the intervention (prehabilitation) will be compared to standard of care in the German health care system using a health cost analysis framework.
Up to one year
Adequacy of exercise interventions
Time Frame: Up to one year
Assessment of the appropriateness of the quantity and quality of the exercise interventions compared to exercise prescription guidelines.
Up to one year
Evaluation of the nutritional intervention
Time Frame: Up to three weeks
Questionnaire on operability of the nutritional intervention and dietary records
Up to three weeks
Anesthesia duration
Time Frame: During surgery
Measured form anesthesia induction until stop of anesthesia (Patient records)
During surgery
Preoperative Cognitive Impairment
Time Frame: At baseline
For NCD diagnosis at baseline (Preoperative Cognitive Impairment) the same distinction criteria for mild and major NCD were applied, although here formal neurocognitive test performance at baseline was compared to the corresponding mean baseline value in the non-surgical control group.
At baseline
Assistive Devices (Hilfsmittel)
Time Frame: Up to one year
The need of any aid and device that is designed, made, or adapted to assist a patient perform a particular task.
Up to one year
Treatment (Heilmittel)
Time Frame: Up to one year
The need of a substance or method for curing an illness.
Up to one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 30, 2020

Primary Completion (Estimated)

July 1, 2024

Study Completion (Estimated)

July 1, 2024

Study Registration Dates

First Submitted

May 19, 2020

First Submitted That Met QC Criteria

June 1, 2020

First Posted (Actual)

June 5, 2020

Study Record Updates

Last Update Posted (Estimated)

February 13, 2024

Last Update Submitted That Met QC Criteria

February 12, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PRAEP-GO
  • U1111-1253-4820 (Other Identifier: Universal Trial Number (UTN))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty

Clinical Trials on Prehabilitation- new form of care

3
Subscribe